The company’s move to drop Eliquis comes as the insurer’s PBM increasingly removes drugs from its formulary, excluding 433 products in 2022, up from 417 the year before.

Join The Ecosystem

Leave a Reply

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}